nodes	percent_of_prediction	percent_of_DWPC	metapath
Imiquimod—CYP3A4—Rosuvastatin—atherosclerosis	0.0679	0.211	CbGbCtD
Imiquimod—CYP3A4—Ezetimibe—atherosclerosis	0.0679	0.211	CbGbCtD
Imiquimod—CYP3A4—Simvastatin—atherosclerosis	0.0631	0.196	CbGbCtD
Imiquimod—CYP3A4—Pravastatin—atherosclerosis	0.0618	0.192	CbGbCtD
Imiquimod—CYP3A4—Lovastatin—atherosclerosis	0.0618	0.192	CbGbCtD
Imiquimod—Myocardial infarction—Pravastatin—atherosclerosis	0.00117	0.00279	CcSEcCtD
Imiquimod—Neuropathy peripheral—Pravastatin—atherosclerosis	0.00117	0.00279	CcSEcCtD
Imiquimod—Urinary tract infection—Pravastatin—atherosclerosis	0.00116	0.00277	CcSEcCtD
Imiquimod—Flushing—Ezetimibe—atherosclerosis	0.00115	0.00275	CcSEcCtD
Imiquimod—Chills—Lovastatin—atherosclerosis	0.00114	0.00272	CcSEcCtD
Imiquimod—Cough—Rosuvastatin—atherosclerosis	0.00113	0.00271	CcSEcCtD
Imiquimod—Angiopathy—Ezetimibe—atherosclerosis	0.00113	0.00269	CcSEcCtD
Imiquimod—Immune system disorder—Ezetimibe—atherosclerosis	0.00112	0.00268	CcSEcCtD
Imiquimod—Erythema multiforme—Simvastatin—atherosclerosis	0.00112	0.00268	CcSEcCtD
Imiquimod—Mediastinal disorder—Ezetimibe—atherosclerosis	0.00112	0.00268	CcSEcCtD
Imiquimod—Sinusitis—Pravastatin—atherosclerosis	0.00112	0.00267	CcSEcCtD
Imiquimod—Alopecia—Lovastatin—atherosclerosis	0.00112	0.00267	CcSEcCtD
Imiquimod—Arthralgia—Rosuvastatin—atherosclerosis	0.00111	0.00265	CcSEcCtD
Imiquimod—Myalgia—Rosuvastatin—atherosclerosis	0.00111	0.00265	CcSEcCtD
Imiquimod—Flushing—Simvastatin—atherosclerosis	0.0011	0.00263	CcSEcCtD
Imiquimod—Alopecia—Ezetimibe—atherosclerosis	0.0011	0.00262	CcSEcCtD
Imiquimod—Haemoglobin—Niacin—atherosclerosis	0.00109	0.00261	CcSEcCtD
Imiquimod—Rhinitis—Niacin—atherosclerosis	0.00109	0.00261	CcSEcCtD
Imiquimod—Mental disorder—Ezetimibe—atherosclerosis	0.00109	0.0026	CcSEcCtD
Imiquimod—Haemorrhage—Niacin—atherosclerosis	0.00109	0.0026	CcSEcCtD
Imiquimod—Erythema—Ezetimibe—atherosclerosis	0.00108	0.00258	CcSEcCtD
Imiquimod—Malnutrition—Ezetimibe—atherosclerosis	0.00108	0.00258	CcSEcCtD
Imiquimod—Rhinitis—Pravastatin—atherosclerosis	0.00107	0.00257	CcSEcCtD
Imiquimod—Back pain—Lovastatin—atherosclerosis	0.00107	0.00255	CcSEcCtD
Imiquimod—Pharyngitis—Pravastatin—atherosclerosis	0.00106	0.00254	CcSEcCtD
Imiquimod—Chills—Simvastatin—atherosclerosis	0.00106	0.00254	CcSEcCtD
Imiquimod—Infection—Rosuvastatin—atherosclerosis	0.00105	0.00252	CcSEcCtD
Imiquimod—Visual impairment—Niacin—atherosclerosis	0.00105	0.0025	CcSEcCtD
Imiquimod—Alopecia—Simvastatin—atherosclerosis	0.00105	0.0025	CcSEcCtD
Imiquimod—Back pain—Ezetimibe—atherosclerosis	0.00105	0.0025	CcSEcCtD
Imiquimod—Nervous system disorder—Rosuvastatin—atherosclerosis	0.00104	0.00249	CcSEcCtD
Imiquimod—Mental disorder—Simvastatin—atherosclerosis	0.00104	0.00248	CcSEcCtD
Imiquimod—Visual impairment—Pravastatin—atherosclerosis	0.00103	0.00247	CcSEcCtD
Imiquimod—Erythema—Simvastatin—atherosclerosis	0.00103	0.00246	CcSEcCtD
Imiquimod—Ill-defined disorder—Lovastatin—atherosclerosis	0.00102	0.00244	CcSEcCtD
Imiquimod—Eye disorder—Niacin—atherosclerosis	0.00102	0.00243	CcSEcCtD
Imiquimod—Tinnitus—Niacin—atherosclerosis	0.00101	0.00242	CcSEcCtD
Imiquimod—Erythema multiforme—Pravastatin—atherosclerosis	0.00101	0.00242	CcSEcCtD
Imiquimod—Flushing—Niacin—atherosclerosis	0.00101	0.00241	CcSEcCtD
Imiquimod—Angioedema—Lovastatin—atherosclerosis	0.00101	0.00241	CcSEcCtD
Imiquimod—Ill-defined disorder—Ezetimibe—atherosclerosis	0.001	0.0024	CcSEcCtD
Imiquimod—Tinnitus—Pravastatin—atherosclerosis	0.000998	0.00239	CcSEcCtD
Imiquimod—Malaise—Lovastatin—atherosclerosis	0.000993	0.00238	CcSEcCtD
Imiquimod—Flushing—Pravastatin—atherosclerosis	0.000993	0.00238	CcSEcCtD
Imiquimod—Angioedema—Ezetimibe—atherosclerosis	0.000987	0.00236	CcSEcCtD
Imiquimod—Angiopathy—Niacin—atherosclerosis	0.000986	0.00236	CcSEcCtD
Imiquimod—Chills—Niacin—atherosclerosis	0.000975	0.00233	CcSEcCtD
Imiquimod—Malaise—Ezetimibe—atherosclerosis	0.000974	0.00233	CcSEcCtD
Imiquimod—Arrhythmia—Niacin—atherosclerosis	0.000971	0.00232	CcSEcCtD
Imiquimod—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	0.000967	0.00231	CcSEcCtD
Imiquimod—Alopecia—Niacin—atherosclerosis	0.00096	0.0023	CcSEcCtD
Imiquimod—Chills—Pravastatin—atherosclerosis	0.00096	0.0023	CcSEcCtD
Imiquimod—Insomnia—Rosuvastatin—atherosclerosis	0.000959	0.00229	CcSEcCtD
Imiquimod—Ill-defined disorder—Simvastatin—atherosclerosis	0.000956	0.00229	CcSEcCtD
Imiquimod—Arrhythmia—Pravastatin—atherosclerosis	0.000956	0.00229	CcSEcCtD
Imiquimod—Palpitations—Ezetimibe—atherosclerosis	0.000955	0.00228	CcSEcCtD
Imiquimod—Paraesthesia—Rosuvastatin—atherosclerosis	0.000953	0.00228	CcSEcCtD
Imiquimod—Malnutrition—Niacin—atherosclerosis	0.000946	0.00226	CcSEcCtD
Imiquimod—Erythema—Niacin—atherosclerosis	0.000946	0.00226	CcSEcCtD
Imiquimod—Alopecia—Pravastatin—atherosclerosis	0.000946	0.00226	CcSEcCtD
Imiquimod—Cough—Ezetimibe—atherosclerosis	0.000943	0.00225	CcSEcCtD
Imiquimod—Angioedema—Simvastatin—atherosclerosis	0.000941	0.00225	CcSEcCtD
Imiquimod—Myalgia—Lovastatin—atherosclerosis	0.000938	0.00224	CcSEcCtD
Imiquimod—Chest pain—Lovastatin—atherosclerosis	0.000938	0.00224	CcSEcCtD
Imiquimod—Arthralgia—Lovastatin—atherosclerosis	0.000938	0.00224	CcSEcCtD
Imiquimod—Anxiety—Lovastatin—atherosclerosis	0.000935	0.00224	CcSEcCtD
Imiquimod—Dyspepsia—Rosuvastatin—atherosclerosis	0.000934	0.00223	CcSEcCtD
Imiquimod—Hypertension—Ezetimibe—atherosclerosis	0.000933	0.00223	CcSEcCtD
Imiquimod—Malaise—Simvastatin—atherosclerosis	0.000929	0.00222	CcSEcCtD
Imiquimod—Discomfort—Lovastatin—atherosclerosis	0.000927	0.00222	CcSEcCtD
Imiquimod—Myalgia—Ezetimibe—atherosclerosis	0.00092	0.0022	CcSEcCtD
Imiquimod—Arthralgia—Ezetimibe—atherosclerosis	0.00092	0.0022	CcSEcCtD
Imiquimod—Chest pain—Ezetimibe—atherosclerosis	0.00092	0.0022	CcSEcCtD
Imiquimod—Dry mouth—Lovastatin—atherosclerosis	0.000917	0.00219	CcSEcCtD
Imiquimod—Unspecified disorder of skin and subcutaneous tissue—Ezetimibe—atherosclerosis	0.000914	0.00218	CcSEcCtD
Imiquimod—Discomfort—Ezetimibe—atherosclerosis	0.000909	0.00217	CcSEcCtD
Imiquimod—Pain—Rosuvastatin—atherosclerosis	0.000907	0.00217	CcSEcCtD
Imiquimod—Dry mouth—Ezetimibe—atherosclerosis	0.0009	0.00215	CcSEcCtD
Imiquimod—Infection—Lovastatin—atherosclerosis	0.000893	0.00214	CcSEcCtD
Imiquimod—Arthralgia—Simvastatin—atherosclerosis	0.000877	0.0021	CcSEcCtD
Imiquimod—Myalgia—Simvastatin—atherosclerosis	0.000877	0.0021	CcSEcCtD
Imiquimod—Chest pain—Simvastatin—atherosclerosis	0.000877	0.0021	CcSEcCtD
Imiquimod—Infection—Ezetimibe—atherosclerosis	0.000876	0.0021	CcSEcCtD
Imiquimod—Feeling abnormal—Rosuvastatin—atherosclerosis	0.000874	0.00209	CcSEcCtD
Imiquimod—Anxiety—Simvastatin—atherosclerosis	0.000874	0.00209	CcSEcCtD
Imiquimod—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.000867	0.00207	CcSEcCtD
Imiquimod—Discomfort—Simvastatin—atherosclerosis	0.000867	0.00207	CcSEcCtD
Imiquimod—Nervous system disorder—Ezetimibe—atherosclerosis	0.000865	0.00207	CcSEcCtD
Imiquimod—Angioedema—Niacin—atherosclerosis	0.000864	0.00207	CcSEcCtD
Imiquimod—Ill-defined disorder—Pravastatin—atherosclerosis	0.000864	0.00207	CcSEcCtD
Imiquimod—Anorexia—Lovastatin—atherosclerosis	0.000857	0.00205	CcSEcCtD
Imiquimod—Skin disorder—Ezetimibe—atherosclerosis	0.000857	0.00205	CcSEcCtD
Imiquimod—Angioedema—Pravastatin—atherosclerosis	0.000851	0.00204	CcSEcCtD
Imiquimod—Syncope—Niacin—atherosclerosis	0.000848	0.00203	CcSEcCtD
Imiquimod—Urticaria—Rosuvastatin—atherosclerosis	0.000843	0.00202	CcSEcCtD
Imiquimod—Oedema—Simvastatin—atherosclerosis	0.000841	0.00201	CcSEcCtD
Imiquimod—Malaise—Pravastatin—atherosclerosis	0.00084	0.00201	CcSEcCtD
Imiquimod—Abdominal pain—Rosuvastatin—atherosclerosis	0.000839	0.00201	CcSEcCtD
Imiquimod—Palpitations—Niacin—atherosclerosis	0.000836	0.002	CcSEcCtD
Imiquimod—Infection—Simvastatin—atherosclerosis	0.000835	0.002	CcSEcCtD
Imiquimod—Loss of consciousness—Niacin—atherosclerosis	0.000832	0.00199	CcSEcCtD
Imiquimod—Cough—Niacin—atherosclerosis	0.000826	0.00197	CcSEcCtD
Imiquimod—Musculoskeletal discomfort—Lovastatin—atherosclerosis	0.000819	0.00196	CcSEcCtD
Imiquimod—Insomnia—Lovastatin—atherosclerosis	0.000813	0.00194	CcSEcCtD
Imiquimod—Cough—Pravastatin—atherosclerosis	0.000813	0.00194	CcSEcCtD
Imiquimod—Paraesthesia—Lovastatin—atherosclerosis	0.000807	0.00193	CcSEcCtD
Imiquimod—Myalgia—Niacin—atherosclerosis	0.000805	0.00193	CcSEcCtD
Imiquimod—Arthralgia—Niacin—atherosclerosis	0.000805	0.00193	CcSEcCtD
Imiquimod—Hypertension—Pravastatin—atherosclerosis	0.000804	0.00192	CcSEcCtD
Imiquimod—Musculoskeletal discomfort—Ezetimibe—atherosclerosis	0.000803	0.00192	CcSEcCtD
Imiquimod—Anorexia—Simvastatin—atherosclerosis	0.000802	0.00192	CcSEcCtD
Imiquimod—Dyspnoea—Lovastatin—atherosclerosis	0.000802	0.00192	CcSEcCtD
Imiquimod—Unspecified disorder of skin and subcutaneous tissue—Niacin—atherosclerosis	0.0008	0.00191	CcSEcCtD
Imiquimod—Insomnia—Ezetimibe—atherosclerosis	0.000798	0.00191	CcSEcCtD
Imiquimod—Arthralgia—Pravastatin—atherosclerosis	0.000793	0.0019	CcSEcCtD
Imiquimod—Myalgia—Pravastatin—atherosclerosis	0.000793	0.0019	CcSEcCtD
Imiquimod—Chest pain—Pravastatin—atherosclerosis	0.000793	0.0019	CcSEcCtD
Imiquimod—Paraesthesia—Ezetimibe—atherosclerosis	0.000792	0.00189	CcSEcCtD
Imiquimod—Dyspepsia—Lovastatin—atherosclerosis	0.000791	0.00189	CcSEcCtD
Imiquimod—Anxiety—Pravastatin—atherosclerosis	0.00079	0.00189	CcSEcCtD
Imiquimod—Dry mouth—Niacin—atherosclerosis	0.000788	0.00188	CcSEcCtD
Imiquimod—Dyspnoea—Ezetimibe—atherosclerosis	0.000786	0.00188	CcSEcCtD
Imiquimod—Discomfort—Pravastatin—atherosclerosis	0.000784	0.00187	CcSEcCtD
Imiquimod—Hypersensitivity—Rosuvastatin—atherosclerosis	0.000782	0.00187	CcSEcCtD
Imiquimod—Decreased appetite—Lovastatin—atherosclerosis	0.000782	0.00187	CcSEcCtD
Imiquimod—Dyspepsia—Ezetimibe—atherosclerosis	0.000776	0.00186	CcSEcCtD
Imiquimod—Fatigue—Lovastatin—atherosclerosis	0.000775	0.00185	CcSEcCtD
Imiquimod—Oedema—Niacin—atherosclerosis	0.000772	0.00185	CcSEcCtD
Imiquimod—Pain—Lovastatin—atherosclerosis	0.000769	0.00184	CcSEcCtD
Imiquimod—Decreased appetite—Ezetimibe—atherosclerosis	0.000767	0.00183	CcSEcCtD
Imiquimod—Musculoskeletal discomfort—Simvastatin—atherosclerosis	0.000766	0.00183	CcSEcCtD
Imiquimod—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.000761	0.00182	CcSEcCtD
Imiquimod—Asthenia—Rosuvastatin—atherosclerosis	0.000761	0.00182	CcSEcCtD
Imiquimod—Insomnia—Simvastatin—atherosclerosis	0.000761	0.00182	CcSEcCtD
Imiquimod—Oedema—Pravastatin—atherosclerosis	0.00076	0.00182	CcSEcCtD
Imiquimod—Fatigue—Ezetimibe—atherosclerosis	0.00076	0.00182	CcSEcCtD
Imiquimod—Shock—Niacin—atherosclerosis	0.00076	0.00182	CcSEcCtD
Imiquimod—Infection—Pravastatin—atherosclerosis	0.000755	0.00181	CcSEcCtD
Imiquimod—Paraesthesia—Simvastatin—atherosclerosis	0.000755	0.00181	CcSEcCtD
Imiquimod—Pain—Ezetimibe—atherosclerosis	0.000754	0.0018	CcSEcCtD
Imiquimod—Tachycardia—Niacin—atherosclerosis	0.000754	0.0018	CcSEcCtD
Imiquimod—Pruritus—Rosuvastatin—atherosclerosis	0.000751	0.0018	CcSEcCtD
Imiquimod—Skin disorder—Niacin—atherosclerosis	0.00075	0.00179	CcSEcCtD
Imiquimod—Dyspnoea—Simvastatin—atherosclerosis	0.00075	0.00179	CcSEcCtD
Imiquimod—Hyperhidrosis—Niacin—atherosclerosis	0.000746	0.00179	CcSEcCtD
Imiquimod—Feeling abnormal—Lovastatin—atherosclerosis	0.000741	0.00177	CcSEcCtD
Imiquimod—Dyspepsia—Simvastatin—atherosclerosis	0.00074	0.00177	CcSEcCtD
Imiquimod—Anorexia—Niacin—atherosclerosis	0.000736	0.00176	CcSEcCtD
Imiquimod—Gastrointestinal pain—Lovastatin—atherosclerosis	0.000735	0.00176	CcSEcCtD
Imiquimod—Hyperhidrosis—Pravastatin—atherosclerosis	0.000735	0.00176	CcSEcCtD
Imiquimod—Decreased appetite—Simvastatin—atherosclerosis	0.000731	0.00175	CcSEcCtD
Imiquimod—Feeling abnormal—Ezetimibe—atherosclerosis	0.000727	0.00174	CcSEcCtD
Imiquimod—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.000726	0.00174	CcSEcCtD
Imiquimod—Diarrhoea—Rosuvastatin—atherosclerosis	0.000726	0.00174	CcSEcCtD
Imiquimod—Fatigue—Simvastatin—atherosclerosis	0.000725	0.00173	CcSEcCtD
Imiquimod—Anorexia—Pravastatin—atherosclerosis	0.000725	0.00173	CcSEcCtD
Imiquimod—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.000721	0.00172	CcSEcCtD
Imiquimod—Pain—Simvastatin—atherosclerosis	0.000719	0.00172	CcSEcCtD
Imiquimod—Urticaria—Lovastatin—atherosclerosis	0.000714	0.00171	CcSEcCtD
Imiquimod—Abdominal pain—Lovastatin—atherosclerosis	0.000711	0.0017	CcSEcCtD
Imiquimod—Body temperature increased—Lovastatin—atherosclerosis	0.000711	0.0017	CcSEcCtD
Imiquimod—Musculoskeletal discomfort—Niacin—atherosclerosis	0.000703	0.00168	CcSEcCtD
Imiquimod—Dizziness—Rosuvastatin—atherosclerosis	0.000702	0.00168	CcSEcCtD
Imiquimod—Urticaria—Ezetimibe—atherosclerosis	0.000701	0.00168	CcSEcCtD
Imiquimod—Insomnia—Niacin—atherosclerosis	0.000698	0.00167	CcSEcCtD
Imiquimod—Abdominal pain—Ezetimibe—atherosclerosis	0.000697	0.00167	CcSEcCtD
Imiquimod—Body temperature increased—Ezetimibe—atherosclerosis	0.000697	0.00167	CcSEcCtD
Imiquimod—Paraesthesia—Niacin—atherosclerosis	0.000693	0.00166	CcSEcCtD
Imiquimod—Feeling abnormal—Simvastatin—atherosclerosis	0.000693	0.00166	CcSEcCtD
Imiquimod—Musculoskeletal discomfort—Pravastatin—atherosclerosis	0.000693	0.00166	CcSEcCtD
Imiquimod—Dyspnoea—Niacin—atherosclerosis	0.000688	0.00165	CcSEcCtD
Imiquimod—Gastrointestinal pain—Simvastatin—atherosclerosis	0.000688	0.00164	CcSEcCtD
Imiquimod—Insomnia—Pravastatin—atherosclerosis	0.000688	0.00164	CcSEcCtD
Imiquimod—Somnolence—Niacin—atherosclerosis	0.000686	0.00164	CcSEcCtD
Imiquimod—Paraesthesia—Pravastatin—atherosclerosis	0.000683	0.00163	CcSEcCtD
Imiquimod—Dyspepsia—Niacin—atherosclerosis	0.00068	0.00163	CcSEcCtD
Imiquimod—Dyspnoea—Pravastatin—atherosclerosis	0.000678	0.00162	CcSEcCtD
Imiquimod—Decreased appetite—Niacin—atherosclerosis	0.000671	0.00161	CcSEcCtD
Imiquimod—Dyspepsia—Pravastatin—atherosclerosis	0.000669	0.0016	CcSEcCtD
Imiquimod—Rash—Rosuvastatin—atherosclerosis	0.000669	0.0016	CcSEcCtD
Imiquimod—Dermatitis—Rosuvastatin—atherosclerosis	0.000668	0.0016	CcSEcCtD
Imiquimod—Urticaria—Simvastatin—atherosclerosis	0.000668	0.0016	CcSEcCtD
Imiquimod—Gastrointestinal disorder—Niacin—atherosclerosis	0.000667	0.00159	CcSEcCtD
Imiquimod—Body temperature increased—Simvastatin—atherosclerosis	0.000665	0.00159	CcSEcCtD
Imiquimod—Abdominal pain—Simvastatin—atherosclerosis	0.000665	0.00159	CcSEcCtD
Imiquimod—Headache—Rosuvastatin—atherosclerosis	0.000665	0.00159	CcSEcCtD
Imiquimod—Hypersensitivity—Lovastatin—atherosclerosis	0.000662	0.00158	CcSEcCtD
Imiquimod—Decreased appetite—Pravastatin—atherosclerosis	0.000661	0.00158	CcSEcCtD
Imiquimod—Pain—Niacin—atherosclerosis	0.00066	0.00158	CcSEcCtD
Imiquimod—Fatigue—Pravastatin—atherosclerosis	0.000655	0.00157	CcSEcCtD
Imiquimod—Pain—Pravastatin—atherosclerosis	0.00065	0.00155	CcSEcCtD
Imiquimod—Hypersensitivity—Ezetimibe—atherosclerosis	0.00065	0.00155	CcSEcCtD
Imiquimod—Asthenia—Lovastatin—atherosclerosis	0.000645	0.00154	CcSEcCtD
Imiquimod—Pruritus—Lovastatin—atherosclerosis	0.000636	0.00152	CcSEcCtD
Imiquimod—Asthenia—Ezetimibe—atherosclerosis	0.000633	0.00151	CcSEcCtD
Imiquimod—Gastrointestinal pain—Niacin—atherosclerosis	0.000631	0.00151	CcSEcCtD
Imiquimod—Nausea—Rosuvastatin—atherosclerosis	0.00063	0.00151	CcSEcCtD
Imiquimod—Feeling abnormal—Pravastatin—atherosclerosis	0.000627	0.0015	CcSEcCtD
Imiquimod—Pruritus—Ezetimibe—atherosclerosis	0.000624	0.00149	CcSEcCtD
Imiquimod—Gastrointestinal pain—Pravastatin—atherosclerosis	0.000622	0.00149	CcSEcCtD
Imiquimod—Hypersensitivity—Simvastatin—atherosclerosis	0.00062	0.00148	CcSEcCtD
Imiquimod—Diarrhoea—Lovastatin—atherosclerosis	0.000615	0.00147	CcSEcCtD
Imiquimod—Urticaria—Niacin—atherosclerosis	0.000613	0.00147	CcSEcCtD
Imiquimod—Body temperature increased—Niacin—atherosclerosis	0.00061	0.00146	CcSEcCtD
Imiquimod—Abdominal pain—Niacin—atherosclerosis	0.00061	0.00146	CcSEcCtD
Imiquimod—Urticaria—Pravastatin—atherosclerosis	0.000604	0.00144	CcSEcCtD
Imiquimod—Asthenia—Simvastatin—atherosclerosis	0.000603	0.00144	CcSEcCtD
Imiquimod—Diarrhoea—Ezetimibe—atherosclerosis	0.000603	0.00144	CcSEcCtD
Imiquimod—Abdominal pain—Pravastatin—atherosclerosis	0.000601	0.00144	CcSEcCtD
Imiquimod—Body temperature increased—Pravastatin—atherosclerosis	0.000601	0.00144	CcSEcCtD
Imiquimod—Pruritus—Simvastatin—atherosclerosis	0.000595	0.00142	CcSEcCtD
Imiquimod—Dizziness—Lovastatin—atherosclerosis	0.000595	0.00142	CcSEcCtD
Imiquimod—Dizziness—Ezetimibe—atherosclerosis	0.000583	0.00139	CcSEcCtD
Imiquimod—Diarrhoea—Simvastatin—atherosclerosis	0.000575	0.00138	CcSEcCtD
Imiquimod—Vomiting—Lovastatin—atherosclerosis	0.000572	0.00137	CcSEcCtD
Imiquimod—Hypersensitivity—Niacin—atherosclerosis	0.000569	0.00136	CcSEcCtD
Imiquimod—Rash—Lovastatin—atherosclerosis	0.000567	0.00136	CcSEcCtD
Imiquimod—Dermatitis—Lovastatin—atherosclerosis	0.000566	0.00135	CcSEcCtD
Imiquimod—Headache—Lovastatin—atherosclerosis	0.000563	0.00135	CcSEcCtD
Imiquimod—Vomiting—Ezetimibe—atherosclerosis	0.000561	0.00134	CcSEcCtD
Imiquimod—Hypersensitivity—Pravastatin—atherosclerosis	0.00056	0.00134	CcSEcCtD
Imiquimod—Dizziness—Simvastatin—atherosclerosis	0.000556	0.00133	CcSEcCtD
Imiquimod—Rash—Ezetimibe—atherosclerosis	0.000556	0.00133	CcSEcCtD
Imiquimod—Dermatitis—Ezetimibe—atherosclerosis	0.000555	0.00133	CcSEcCtD
Imiquimod—TLR7—Innate Immune System—CD14—atherosclerosis	0.000555	0.00214	CbGpPWpGaD
Imiquimod—Asthenia—Niacin—atherosclerosis	0.000554	0.00132	CcSEcCtD
Imiquimod—Headache—Ezetimibe—atherosclerosis	0.000552	0.00132	CcSEcCtD
Imiquimod—TLR8—Regulation of toll-like receptor signaling pathway—AKT1—atherosclerosis	0.000551	0.00213	CbGpPWpGaD
Imiquimod—Pruritus—Niacin—atherosclerosis	0.000546	0.00131	CcSEcCtD
Imiquimod—Asthenia—Pravastatin—atherosclerosis	0.000545	0.0013	CcSEcCtD
Imiquimod—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP7A1—atherosclerosis	0.000544	0.0021	CbGpPWpGaD
Imiquimod—TLR8—Immune System—NCF1—atherosclerosis	0.000539	0.00208	CbGpPWpGaD
Imiquimod—Pruritus—Pravastatin—atherosclerosis	0.000538	0.00129	CcSEcCtD
Imiquimod—CYP3A4—Oxidation by Cytochrome P450—CYP7A1—atherosclerosis	0.000537	0.00207	CbGpPWpGaD
Imiquimod—TLR8—Innate Immune System—PDGFB—atherosclerosis	0.000536	0.00207	CbGpPWpGaD
Imiquimod—TLR7—Toll-like Receptor Signaling Pathway—AKT1—atherosclerosis	0.000535	0.00206	CbGpPWpGaD
Imiquimod—Vomiting—Simvastatin—atherosclerosis	0.000535	0.00128	CcSEcCtD
Imiquimod—Nausea—Lovastatin—atherosclerosis	0.000534	0.00128	CcSEcCtD
Imiquimod—Rash—Simvastatin—atherosclerosis	0.00053	0.00127	CcSEcCtD
Imiquimod—Dermatitis—Simvastatin—atherosclerosis	0.00053	0.00127	CcSEcCtD
Imiquimod—Diarrhoea—Niacin—atherosclerosis	0.000528	0.00126	CcSEcCtD
Imiquimod—CYP1A2—Phase 1 - Functionalization of compounds—CYP27A1—atherosclerosis	0.000528	0.00204	CbGpPWpGaD
Imiquimod—Headache—Simvastatin—atherosclerosis	0.000527	0.00126	CcSEcCtD
Imiquimod—CYP1A2—Melatonin metabolism and effects—EDN1—atherosclerosis	0.000527	0.00203	CbGpPWpGaD
Imiquimod—TLR8—Innate Immune System—CRP—atherosclerosis	0.000524	0.00202	CbGpPWpGaD
Imiquimod—Nausea—Ezetimibe—atherosclerosis	0.000524	0.00125	CcSEcCtD
Imiquimod—Diarrhoea—Pravastatin—atherosclerosis	0.00052	0.00124	CcSEcCtD
Imiquimod—Dizziness—Niacin—atherosclerosis	0.000511	0.00122	CcSEcCtD
Imiquimod—TLR8—Immune System—CCR2—atherosclerosis	0.000509	0.00196	CbGpPWpGaD
Imiquimod—TLR8—Immune System—CYBA—atherosclerosis	0.000507	0.00196	CbGpPWpGaD
Imiquimod—Dizziness—Pravastatin—atherosclerosis	0.000503	0.0012	CcSEcCtD
Imiquimod—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP27A1—atherosclerosis	0.000503	0.00194	CbGpPWpGaD
Imiquimod—TLR8—Innate Immune System—TLR4—atherosclerosis	0.000502	0.00194	CbGpPWpGaD
Imiquimod—Nausea—Simvastatin—atherosclerosis	0.000499	0.00119	CcSEcCtD
Imiquimod—CYP3A4—Oxidation by Cytochrome P450—CYP27A1—atherosclerosis	0.000496	0.00191	CbGpPWpGaD
Imiquimod—Vomiting—Niacin—atherosclerosis	0.000491	0.00117	CcSEcCtD
Imiquimod—Rash—Niacin—atherosclerosis	0.000487	0.00116	CcSEcCtD
Imiquimod—Dermatitis—Niacin—atherosclerosis	0.000486	0.00116	CcSEcCtD
Imiquimod—Headache—Niacin—atherosclerosis	0.000484	0.00116	CcSEcCtD
Imiquimod—Vomiting—Pravastatin—atherosclerosis	0.000483	0.00116	CcSEcCtD
Imiquimod—Rash—Pravastatin—atherosclerosis	0.000479	0.00115	CcSEcCtD
Imiquimod—Dermatitis—Pravastatin—atherosclerosis	0.000479	0.00115	CcSEcCtD
Imiquimod—Headache—Pravastatin—atherosclerosis	0.000476	0.00114	CcSEcCtD
Imiquimod—TLR8—Immune System—CD40—atherosclerosis	0.000474	0.00183	CbGpPWpGaD
Imiquimod—TLR8—Immune System—TLR2—atherosclerosis	0.000474	0.00183	CbGpPWpGaD
Imiquimod—Nausea—Niacin—atherosclerosis	0.000459	0.0011	CcSEcCtD
Imiquimod—TLR7—Innate Immune System—AGER—atherosclerosis	0.000455	0.00176	CbGpPWpGaD
Imiquimod—TLR7—Regulation of toll-like receptor signaling pathway—IL6—atherosclerosis	0.000453	0.00175	CbGpPWpGaD
Imiquimod—Nausea—Pravastatin—atherosclerosis	0.000452	0.00108	CcSEcCtD
Imiquimod—TLR7—Innate Immune System—PRKCG—atherosclerosis	0.000451	0.00174	CbGpPWpGaD
Imiquimod—TLR7—Toll-Like Receptors Cascades—IL6—atherosclerosis	0.000448	0.00173	CbGpPWpGaD
Imiquimod—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—atherosclerosis	0.000442	0.00171	CbGpPWpGaD
Imiquimod—CYP3A4—Phase 1 - Functionalization of compounds—CYP7A1—atherosclerosis	0.000441	0.0017	CbGpPWpGaD
Imiquimod—TLR7—Innate Immune System—CD36—atherosclerosis	0.00044	0.0017	CbGpPWpGaD
Imiquimod—CYP1A2—Estrogen Receptor Pathway—STAT3—atherosclerosis	0.000435	0.00168	CbGpPWpGaD
Imiquimod—CYP1A2—Melatonin metabolism and effects—APOE—atherosclerosis	0.000428	0.00165	CbGpPWpGaD
Imiquimod—TLR8—Immune System—CD14—atherosclerosis	0.000427	0.00165	CbGpPWpGaD
Imiquimod—TLR7—Regulation of toll-like receptor signaling pathway—AKT1—atherosclerosis	0.000418	0.00161	CbGpPWpGaD
Imiquimod—TLR8—Immune System—VCAM1—atherosclerosis	0.000412	0.00159	CbGpPWpGaD
Imiquimod—TLR7—Immune System—NCF1—atherosclerosis	0.000409	0.00158	CbGpPWpGaD
Imiquimod—CYP3A4—Phase 1 - Functionalization of compounds—CYP27A1—atherosclerosis	0.000407	0.00157	CbGpPWpGaD
Imiquimod—TLR7—Innate Immune System—PDGFB—atherosclerosis	0.000406	0.00157	CbGpPWpGaD
Imiquimod—TLR8—Immune System—SOCS3—atherosclerosis	0.0004	0.00154	CbGpPWpGaD
Imiquimod—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—atherosclerosis	0.000397	0.00153	CbGpPWpGaD
Imiquimod—TLR7—Innate Immune System—CRP—atherosclerosis	0.000397	0.00153	CbGpPWpGaD
Imiquimod—TLR7—Immune System—CCR2—atherosclerosis	0.000386	0.00149	CbGpPWpGaD
Imiquimod—TLR7—Immune System—CYBA—atherosclerosis	0.000384	0.00148	CbGpPWpGaD
Imiquimod—TLR7—Innate Immune System—TLR4—atherosclerosis	0.000381	0.00147	CbGpPWpGaD
Imiquimod—TLR8—Immune System—IL18—atherosclerosis	0.000364	0.0014	CbGpPWpGaD
Imiquimod—TLR8—Immune System—CD40LG—atherosclerosis	0.000363	0.0014	CbGpPWpGaD
Imiquimod—TLR7—Immune System—TLR2—atherosclerosis	0.000359	0.00138	CbGpPWpGaD
Imiquimod—TLR7—Immune System—CD40—atherosclerosis	0.000359	0.00138	CbGpPWpGaD
Imiquimod—CYP1A2—Aryl Hydrocarbon Receptor—LPL—atherosclerosis	0.000353	0.00136	CbGpPWpGaD
Imiquimod—TLR8—Immune System—AGER—atherosclerosis	0.00035	0.00135	CbGpPWpGaD
Imiquimod—TLR8—Immune System—PRKCG—atherosclerosis	0.000346	0.00134	CbGpPWpGaD
Imiquimod—TLR8—Immune System—CD36—atherosclerosis	0.000338	0.00131	CbGpPWpGaD
Imiquimod—CYP1A2—Aryl Hydrocarbon Receptor—CD36—atherosclerosis	0.000336	0.00129	CbGpPWpGaD
Imiquimod—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—atherosclerosis	0.000328	0.00127	CbGpPWpGaD
Imiquimod—TLR7—Immune System—CD14—atherosclerosis	0.000323	0.00125	CbGpPWpGaD
Imiquimod—CYP1A2—Arachidonic acid metabolism—GPX1—atherosclerosis	0.000322	0.00124	CbGpPWpGaD
Imiquimod—TLR7—Immune System—VCAM1—atherosclerosis	0.000312	0.0012	CbGpPWpGaD
Imiquimod—TLR8—Immune System—PDGFB—atherosclerosis	0.000312	0.0012	CbGpPWpGaD
Imiquimod—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—atherosclerosis	0.000307	0.00118	CbGpPWpGaD
Imiquimod—TLR8—Immune System—CRP—atherosclerosis	0.000305	0.00118	CbGpPWpGaD
Imiquimod—TLR8—Innate Immune System—NFKB1—atherosclerosis	0.000305	0.00118	CbGpPWpGaD
Imiquimod—CYP1A2—Biological oxidations—CYP7A1—atherosclerosis	0.000303	0.00117	CbGpPWpGaD
Imiquimod—TLR7—Immune System—SOCS3—atherosclerosis	0.000303	0.00117	CbGpPWpGaD
Imiquimod—TLR8—Innate Immune System—MAPK8—atherosclerosis	0.0003	0.00116	CbGpPWpGaD
Imiquimod—CYP1A2—Metapathway biotransformation—CYP7A1—atherosclerosis	0.000299	0.00115	CbGpPWpGaD
Imiquimod—TLR8—Immune System—TLR4—atherosclerosis	0.000293	0.00113	CbGpPWpGaD
Imiquimod—CYP1A2—Aryl Hydrocarbon Receptor—ESR1—atherosclerosis	0.000283	0.00109	CbGpPWpGaD
Imiquimod—TLR8—Immune System—ICAM1—atherosclerosis	0.00028	0.00108	CbGpPWpGaD
Imiquimod—CYP1A2—Biological oxidations—CYP27A1—atherosclerosis	0.00028	0.00108	CbGpPWpGaD
Imiquimod—CYP1A2—Metapathway biotransformation—CYP27A1—atherosclerosis	0.000277	0.00107	CbGpPWpGaD
Imiquimod—TLR7—Immune System—IL18—atherosclerosis	0.000276	0.00106	CbGpPWpGaD
Imiquimod—TLR7—Immune System—CD40LG—atherosclerosis	0.000275	0.00106	CbGpPWpGaD
Imiquimod—TLR7—Immune System—AGER—atherosclerosis	0.000265	0.00102	CbGpPWpGaD
Imiquimod—TLR7—Immune System—PRKCG—atherosclerosis	0.000263	0.00101	CbGpPWpGaD
Imiquimod—TLR8—Innate Immune System—MAPK3—atherosclerosis	0.000262	0.00101	CbGpPWpGaD
Imiquimod—TLR7—Immune System—CD36—atherosclerosis	0.000257	0.000989	CbGpPWpGaD
Imiquimod—CYP1A2—Melatonin metabolism and effects—NFKB1—atherosclerosis	0.000255	0.000982	CbGpPWpGaD
Imiquimod—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—atherosclerosis	0.000253	0.000977	CbGpPWpGaD
Imiquimod—TLR7—Immune System—PDGFB—atherosclerosis	0.000237	0.000912	CbGpPWpGaD
Imiquimod—CYP3A4—Biological oxidations—CYP7A1—atherosclerosis	0.000234	0.000903	CbGpPWpGaD
Imiquimod—TLR7—Immune System—CRP—atherosclerosis	0.000231	0.000892	CbGpPWpGaD
Imiquimod—TLR7—Innate Immune System—NFKB1—atherosclerosis	0.000231	0.000891	CbGpPWpGaD
Imiquimod—CYP3A4—Metapathway biotransformation—CYP7A1—atherosclerosis	0.000231	0.000891	CbGpPWpGaD
Imiquimod—TLR7—Innate Immune System—MAPK8—atherosclerosis	0.000227	0.000876	CbGpPWpGaD
Imiquimod—TLR7—Immune System—TLR4—atherosclerosis	0.000222	0.000855	CbGpPWpGaD
Imiquimod—CYP3A4—Biological oxidations—CYP27A1—atherosclerosis	0.000216	0.000835	CbGpPWpGaD
Imiquimod—CYP1A2—Phase II conjugation—GSTM1—atherosclerosis	0.000214	0.000826	CbGpPWpGaD
Imiquimod—CYP3A4—Metapathway biotransformation—CYP27A1—atherosclerosis	0.000213	0.000823	CbGpPWpGaD
Imiquimod—TLR8—Immune System—IFNG—atherosclerosis	0.000213	0.000823	CbGpPWpGaD
Imiquimod—TLR7—Immune System—ICAM1—atherosclerosis	0.000213	0.00082	CbGpPWpGaD
Imiquimod—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—atherosclerosis	0.000212	0.000816	CbGpPWpGaD
Imiquimod—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—atherosclerosis	0.000203	0.000782	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—LDLRAP1—atherosclerosis	0.000199	0.000769	CbGpPWpGaD
Imiquimod—TLR7—Innate Immune System—MAPK3—atherosclerosis	0.000198	0.000765	CbGpPWpGaD
Imiquimod—TLR8—Innate Immune System—IL6—atherosclerosis	0.000191	0.000738	CbGpPWpGaD
Imiquimod—TLR8—Immune System—IL1B—atherosclerosis	0.00019	0.000734	CbGpPWpGaD
Imiquimod—CYP1A2—Arachidonic acid metabolism—PTGS2—atherosclerosis	0.00019	0.000732	CbGpPWpGaD
Imiquimod—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—atherosclerosis	0.000189	0.000728	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—PLTP—atherosclerosis	0.000188	0.000723	CbGpPWpGaD
Imiquimod—TLR8—Immune System—NFKB1—atherosclerosis	0.000178	0.000685	CbGpPWpGaD
Imiquimod—TLR8—Innate Immune System—AKT1—atherosclerosis	0.000177	0.000681	CbGpPWpGaD
Imiquimod—CYP1A2—Aryl Hydrocarbon Receptor—NFKB1—atherosclerosis	0.000176	0.000679	CbGpPWpGaD
Imiquimod—TLR8—Immune System—MAPK8—atherosclerosis	0.000175	0.000673	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—LTA4H—atherosclerosis	0.000163	0.000627	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—ABCG8—atherosclerosis	0.000163	0.000627	CbGpPWpGaD
Imiquimod—TLR7—Immune System—IFNG—atherosclerosis	0.000162	0.000624	CbGpPWpGaD
Imiquimod—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—atherosclerosis	0.00016	0.000616	CbGpPWpGaD
Imiquimod—TLR8—Immune System—STAT3—atherosclerosis	0.00016	0.000615	CbGpPWpGaD
Imiquimod—TLR8—Immune System—MAPK3—atherosclerosis	0.000152	0.000588	CbGpPWpGaD
Imiquimod—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—atherosclerosis	0.000147	0.000566	CbGpPWpGaD
Imiquimod—TLR7—Innate Immune System—IL6—atherosclerosis	0.000145	0.000559	CbGpPWpGaD
Imiquimod—TLR7—Immune System—IL1B—atherosclerosis	0.000144	0.000556	CbGpPWpGaD
Imiquimod—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—atherosclerosis	0.000137	0.000528	CbGpPWpGaD
Imiquimod—CYP1A2—Aryl Hydrocarbon Receptor—TNF—atherosclerosis	0.000137	0.000528	CbGpPWpGaD
Imiquimod—TLR7—Immune System—NFKB1—atherosclerosis	0.000135	0.000519	CbGpPWpGaD
Imiquimod—TLR7—Innate Immune System—AKT1—atherosclerosis	0.000134	0.000516	CbGpPWpGaD
Imiquimod—TLR7—Immune System—MAPK8—atherosclerosis	0.000132	0.00051	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—ABCG1—atherosclerosis	0.000129	0.000496	CbGpPWpGaD
Imiquimod—CYP1A2—Biological oxidations—GSTM1—atherosclerosis	0.000125	0.000483	CbGpPWpGaD
Imiquimod—CYP1A2—Metapathway biotransformation—GSTM1—atherosclerosis	0.000124	0.000476	CbGpPWpGaD
Imiquimod—TLR7—Immune System—STAT3—atherosclerosis	0.000121	0.000466	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—FABP4—atherosclerosis	0.000121	0.000466	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—LCAT—atherosclerosis	0.000121	0.000466	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—APOA4—atherosclerosis	0.000119	0.000457	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—CYP7A1—atherosclerosis	0.000117	0.000449	CbGpPWpGaD
Imiquimod—TLR7—Immune System—MAPK3—atherosclerosis	0.000116	0.000446	CbGpPWpGaD
Imiquimod—TLR8—Immune System—IL6—atherosclerosis	0.000111	0.00043	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—CYP27A1—atherosclerosis	0.000108	0.000415	CbGpPWpGaD
Imiquimod—TLR8—Immune System—AKT1—atherosclerosis	0.000103	0.000397	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—ALOX15—atherosclerosis	0.000102	0.000394	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—ALOX5AP—atherosclerosis	0.000102	0.000394	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G2A—atherosclerosis	0.000102	0.000394	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—APOA2—atherosclerosis	0.000102	0.000394	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—ABCG5—atherosclerosis	0.000101	0.000389	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—LPA—atherosclerosis	9.74e-05	0.000376	CbGpPWpGaD
Imiquimod—CYP3A4—Biological oxidations—GSTM1—atherosclerosis	9.67e-05	0.000373	CbGpPWpGaD
Imiquimod—CYP3A4—Metapathway biotransformation—GSTM1—atherosclerosis	9.54e-05	0.000368	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—APOA5—atherosclerosis	9.34e-05	0.00036	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G1B—atherosclerosis	8.99e-05	0.000347	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—LDLRAP1—atherosclerosis	8.88e-05	0.000343	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—ALOX5—atherosclerosis	8.68e-05	0.000335	CbGpPWpGaD
Imiquimod—TLR7—Immune System—IL6—atherosclerosis	8.45e-05	0.000326	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—PLTP—atherosclerosis	8.35e-05	0.000322	CbGpPWpGaD
Imiquimod—TLR7—Immune System—AKT1—atherosclerosis	7.79e-05	0.000301	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—LIPC—atherosclerosis	7.74e-05	0.000298	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—APOC3—atherosclerosis	7.69e-05	0.000297	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—LDLR—atherosclerosis	7.64e-05	0.000295	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—CETP—atherosclerosis	7.47e-05	0.000288	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—ABCG8—atherosclerosis	7.24e-05	0.000279	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—LTA4H—atherosclerosis	7.24e-05	0.000279	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—SCARB1—atherosclerosis	7.15e-05	0.000276	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—LDLRAP1—atherosclerosis	6.86e-05	0.000264	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—HMGCR—atherosclerosis	6.75e-05	0.00026	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—PLTP—atherosclerosis	6.45e-05	0.000249	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—ABCA1—atherosclerosis	6.02e-05	0.000232	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—ABCG1—atherosclerosis	5.72e-05	0.000221	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—LTA4H—atherosclerosis	5.59e-05	0.000215	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—ABCG8—atherosclerosis	5.59e-05	0.000215	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—LCAT—atherosclerosis	5.38e-05	0.000208	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—FABP4—atherosclerosis	5.38e-05	0.000208	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—APOA4—atherosclerosis	5.28e-05	0.000204	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—CYP7A1—atherosclerosis	5.19e-05	0.0002	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—APOB—atherosclerosis	4.95e-05	0.000191	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—CYP27A1—atherosclerosis	4.8e-05	0.000185	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—LPL—atherosclerosis	4.72e-05	0.000182	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—atherosclerosis	4.61e-05	0.000178	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—PLA2G2A—atherosclerosis	4.55e-05	0.000175	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—ALOX5AP—atherosclerosis	4.55e-05	0.000175	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—APOA2—atherosclerosis	4.55e-05	0.000175	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—ALOX15—atherosclerosis	4.55e-05	0.000175	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—ABCG5—atherosclerosis	4.49e-05	0.000173	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	4.49e-05	0.000173	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—ABCG1—atherosclerosis	4.42e-05	0.00017	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—LPA—atherosclerosis	4.34e-05	0.000167	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—BGN—atherosclerosis	4.2e-05	0.000162	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	4.17e-05	0.000161	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—APOA5—atherosclerosis	4.16e-05	0.00016	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—LCAT—atherosclerosis	4.15e-05	0.00016	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—FABP4—atherosclerosis	4.15e-05	0.00016	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—APOA4—atherosclerosis	4.08e-05	0.000157	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	4.04e-05	0.000156	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—CYP7A1—atherosclerosis	4e-05	0.000154	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—PLA2G1B—atherosclerosis	4e-05	0.000154	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	3.96e-05	0.000153	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	3.92e-05	0.000151	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	3.91e-05	0.000151	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—ALOX5—atherosclerosis	3.87e-05	0.000149	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—CYP27A1—atherosclerosis	3.7e-05	0.000143	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	3.57e-05	0.000138	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—APOA2—atherosclerosis	3.51e-05	0.000135	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—ALOX5AP—atherosclerosis	3.51e-05	0.000135	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—ALOX15—atherosclerosis	3.51e-05	0.000135	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—PLA2G2A—atherosclerosis	3.51e-05	0.000135	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—NAMPT—atherosclerosis	3.47e-05	0.000134	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—ABCG5—atherosclerosis	3.47e-05	0.000134	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	3.45e-05	0.000133	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—LIPC—atherosclerosis	3.45e-05	0.000133	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—APOC3—atherosclerosis	3.42e-05	0.000132	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—LDLR—atherosclerosis	3.4e-05	0.000131	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—LPA—atherosclerosis	3.35e-05	0.000129	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—CETP—atherosclerosis	3.32e-05	0.000128	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—BGN—atherosclerosis	3.24e-05	0.000125	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—APOA5—atherosclerosis	3.21e-05	0.000124	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—SCARB1—atherosclerosis	3.18e-05	0.000123	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	3.1e-05	0.00012	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—PLA2G1B—atherosclerosis	3.09e-05	0.000119	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—HMGCR—atherosclerosis	3.01e-05	0.000116	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—ALOX5—atherosclerosis	2.98e-05	0.000115	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	2.71e-05	0.000105	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—ABCA1—atherosclerosis	2.68e-05	0.000103	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—NAMPT—atherosclerosis	2.68e-05	0.000103	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—LIPC—atherosclerosis	2.66e-05	0.000103	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—APOC3—atherosclerosis	2.64e-05	0.000102	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—LDLR—atherosclerosis	2.63e-05	0.000101	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—CETP—atherosclerosis	2.57e-05	9.89e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—SCARB1—atherosclerosis	2.46e-05	9.48e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—HMGCR—atherosclerosis	2.32e-05	8.95e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—HMOX1—atherosclerosis	2.3e-05	8.87e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—APOB—atherosclerosis	2.2e-05	8.49e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—GSTM1—atherosclerosis	2.14e-05	8.26e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—LPL—atherosclerosis	2.1e-05	8.11e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—ABCA1—atherosclerosis	2.07e-05	7.98e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—GPX1—atherosclerosis	2.05e-05	7.91e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—CD36—atherosclerosis	2e-05	7.7e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—MTHFR—atherosclerosis	1.89e-05	7.3e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—PPARA—atherosclerosis	1.86e-05	7.16e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—AGT—atherosclerosis	1.8e-05	6.94e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—HMOX1—atherosclerosis	1.77e-05	6.84e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—APOE—atherosclerosis	1.76e-05	6.8e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—CAV1—atherosclerosis	1.75e-05	6.73e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—APOA1—atherosclerosis	1.74e-05	6.72e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—APOB—atherosclerosis	1.7e-05	6.55e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—GSTM1—atherosclerosis	1.65e-05	6.38e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—LPL—atherosclerosis	1.62e-05	6.26e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—PIK3CG—atherosclerosis	1.59e-05	6.13e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—GPX1—atherosclerosis	1.58e-05	6.11e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—CD36—atherosclerosis	1.54e-05	5.95e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—PPARG—atherosclerosis	1.54e-05	5.92e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—INS—atherosclerosis	1.51e-05	5.81e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—MTHFR—atherosclerosis	1.46e-05	5.63e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—PPARA—atherosclerosis	1.43e-05	5.53e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—AGT—atherosclerosis	1.39e-05	5.35e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—ALB—atherosclerosis	1.38e-05	5.32e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—APOE—atherosclerosis	1.36e-05	5.25e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—CAV1—atherosclerosis	1.35e-05	5.2e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—APOA1—atherosclerosis	1.34e-05	5.19e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—NOS3—atherosclerosis	1.32e-05	5.09e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—PIK3CG—atherosclerosis	1.23e-05	4.73e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—PTGS2—atherosclerosis	1.21e-05	4.66e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—PPARG—atherosclerosis	1.18e-05	4.57e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—INS—atherosclerosis	1.16e-05	4.48e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—ALB—atherosclerosis	1.07e-05	4.11e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—NOS3—atherosclerosis	1.02e-05	3.93e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—PTGS2—atherosclerosis	9.32e-06	3.59e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—AKT1—atherosclerosis	6.07e-06	2.34e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—AKT1—atherosclerosis	4.68e-06	1.81e-05	CbGpPWpGaD
